Evidence map›Paper›PMID 35607911›Full record

ArticleAnaesthesia2022

Right ventricular dysfunction in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated: a multicentre prospective cohort study.

P J McCall, J M Willder, B L Stanley, C-M Messow, J Allan, L Gemmell, A Puxty, D Strachan, C Berry, B G Shelley and 1 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Anaesthesia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

P J McCallThe Anaesthesia, Critical Care and Peri-operative Medicine Research Group, University of Glasgow, UK.ORCID 0000-0001-5828-3371
J M WillderWest of Scotland School of Anaesthesia, NHS Education for Scotland, Glasgow, UK.
B L StanleyRobertson Centre for Biostatistics, University of Glasgow, UK.
C-M MessowRobertson Centre for Biostatistics, University of Glasgow, UK.
J AllanDepartment of Intensive Care Medicine, University Hospital Crosshouse, Kilmarnock, UK.
L GemmellDepartment of Intensive Care Medicine, Royal Alexandra Hospital, Paisley, UK.
A PuxtyDepartment of Intensive Care Medicine, Glasgow Royal Infirmary, Glasgow, UK.
D StrachanDepartment of Intensive Care Medicine, University Hospital Wishaw, UK.
C BerryDepartment of Cardiology and Imaging, Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK.
B G ShelleyDepartment of Anaesthesia, Golden Jubilee National Hospital, Clydebank, UK.
COVID-RV co-investigators
University of Glasgow · GBGolden Jubilee National Hospital · GBGlasgow Royal Infirmary · GBNHS Education for Scotland · GBRoyal Alexandra Hospital · GBTiGenix (Spain) · ESUniversity Hospital Crosshouse · GBWishaw General Hospital · GB

Funding

British Heart Foundation PG/19/28/34310British Heart Foundation RE/18/6134217Chief Scientist Office EP/R511705/1Chief Scientist Office EP/S030875/1Medical Research Council MC_PC_20014Medical Research Council MR/S018905/1
6 · The paper itself

Abstract

Cardiovascular complications due to COVID-19, such as right ventricular dysfunction, are common. The combination of acute respiratory distress syndrome, invasive mechanical ventilation, thromboembolic disease and direct myocardial injury creates conditions where right ventricular dysfunction is likely to occur. We undertook a prospective, multicentre cohort study in 10 Scottish intensive care units of patients with COVID-19 pneumonitis whose lungs were mechanically ventilated. Right ventricular dysfunction was defined as the presence of severe right ventricular dilation and interventricular septal flattening. To explore the role of myocardial injury, high-sensitivity troponin and N-terminal pro B-type natriuretic peptide plasma levels were measured in all patients. We recruited 121 patients and 118 (98%) underwent imaging. It was possible to determine the primary outcome in 112 (91%). Severe right ventricular dilation was present in 31 (28%), with interventricular septal flattening present in nine (8%). Right ventricular dysfunction (the combination of these two parameters) was present in seven (6%, 95%CI 3-13%). Thirty-day mortality was 86% in those with right ventricular dysfunction as compared with 45% in those without (p = 0.051). Patients with right ventricular dysfunction were more likely to have: pulmonary thromboembolism (p < 0.001); higher plateau airway pressure (p = 0.048); lower dynamic compliance (p = 0.031); higher plasma N-terminal pro B-type natriuretic peptide levels (p = 0.006); and raised plasma troponin levels (p = 0.048). Our results demonstrate a prevalence of right ventricular dysfunction of 6%, which was associated with increased mortality (86%). Associations were also observed between right ventricular dysfunction and aetiological domains of: acute respiratory distress syndrome; ventilation; thromboembolic disease; and direct myocardial injury, implying a complex multifactorial pathophysiology.

Indexed as

COVID-19Respiratory Distress SyndromeVentricular Dysfunction, RightCohort StudiesHumansLungNatriuretic Peptide, BrainProspective StudiesRespiration, ArtificialTroponinNatriuretic Peptide, BrainTroponinARDSCOVID-19echocardiographyright ventricle

Identifiers

PMID35607911
PMCPMC9322018
OpenAlexW4282924675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.